1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
(
- Contribution to journal › Letter
- 2022
-
Mark
Design of an integrated continuous downstream process for acid-sensitive monoclonal antibodies based on a calcium-dependent Protein A ligand
(
- Contribution to journal › Article
-
Mark
Integrated continuous biomanufacturing on pilot scale for acid-sensitive monoclonal antibodies
(
- Contribution to journal › Article
-
Mark
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
(
- Contribution to journal › Letter
- 2021
-
Mark
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay
(
- Contribution to journal › Article
- 2020
-
Mark
HER2-specific pseudomonas exotoxin a pe25 based fusions : Influence of targeting domain on target binding, toxicity, and in vivo biodistribution
(
- Contribution to journal › Article
- 2018
-
Mark
Protein Engineering Allows for Mild Affinity-based Elution of Therapeutic Antibodies
(
- Contribution to journal › Article
- 2017
-
Mark
A pathology atlas of the human cancer transcriptome
(
- Contribution to journal › Article
- 2015
-
Mark
Use of ENCODE Resources to Characterize Novel Proteoforms and Missing Proteins in the Human Proteome
(
- Contribution to journal › Article
- 2013
-
Mark
Developments in Biobanking Workflow Standardization Providing Samples Integrity and Stability
(
- Contribution to journal › Scientific review